Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)

Journal of Basic Microbiology
Azmi Johari SaifulAbdul Manaf Ali

Abstract

Efflux-mediated resistance has been recognized as an important contributor of antibiotic resistance in bacteria, especially in methicillin-resistant Staphylococcus aureus (MRSA) isolates. This study was carried out to detect and analyze efflux genes (norA and mdeA) and active efflux activity in a collection of Malaysian MRSA and methicillin-sensitive S. aureus (MSSA) clinical isolates. Nineteen isolates including three ATCC S. aureus reference strains were subjected to PCR detection and DNA sequence analysis for norA and mdeA and active efflux detection using modified minimum inhibitory concentration (MIC) assay. From the 19 isolates, 18 isolates harboured the mdeA gene while 16 isolates contained norA gene. DNA sequence analysis reveals 98-100% correlation between the PCR product and the published DNA sequences in GenBank. In addition, 16 isolates exhibited active efflux activity using the ethidium bromide (EtBr)-reserpine combination MIC assay. To our knowledge, this is the first report on the detection of efflux genes and active efflux activity amongst Malaysian clinical isolates of MRSA/MSSA. Detection of active efflux activity may explain the previous report on efflux-mediated drug resistance profile amongst the local clin...Continue Reading

References

Jan 1, 1993·Antimicrobial Agents and Chemotherapy·A A NeyfakhG W Kaatz
May 1, 1993·Antimicrobial Agents and Chemotherapy·G W KaatzC A Ruble
Mar 21, 2000·International Journal of Antimicrobial Agents·M Y RohaniT Zainuldin
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·M PutmanW N Konings
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·J R FitzgeraldJ M Musser
Sep 20, 2001·Current Medicinal Chemistry·O Lomovskaya, W J Watkins
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Simon GibbonsGlenn W Kaatz
Sep 19, 2003·International Journal of Antimicrobial Agents·Malthe M KristiansenLeonard Amaral
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Jianzhong HuangDamien McDevitt
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Matthew T G HoldenJulian Parkhill
Nov 25, 2004·Phytochemistry·Moyosoluwa OluwatuyiSimon Gibbons
Apr 26, 2005·International Journal of Antimicrobial Agents·Norihisa NoguchiMasanori Sasatsu
May 26, 2005·The Journal of Antimicrobial Chemotherapy·Keith Poole
Mar 2, 2006·Biological & Pharmaceutical Bulletin·Youichi YamadaTomofusa Tsuchiya
Apr 6, 2006·Biological & Pharmaceutical Bulletin·Youichi YamadaTomofusa Tsuchiya
Jul 29, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Heiman F L WertheimWytske Fokkens

❮ Previous
Next ❯

Citations

Aug 1, 2012·Foodborne Pathogens and Disease·Young-Seob LeeDong-Yeul Kwon
Oct 20, 2011·The Journal of Toxicological Sciences·Young-Seob LeeDong-Yeul Kwon
Dec 26, 2012·Journal of Ethnopharmacology·Ahmad Nazif AzizKhalijah Awang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.